| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2022-08-12 | 2022-03-31 | 2021-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 1.15 | 0.785 | 0 |
| Gross Profit | -1.15 | -0.785 | 0 |
| Operating Expenses | -0.275 | 0 | 0.085 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 0.605 | 0 | 0 |
| Other Operating Expenses | -0.879 | 0 | 0.085 |
| Operating Income | -0.872 | -0.785 | -0.085 |
| Net Non-Operating Interest | 8.97 | 20.18 | 0 |
| Interest Income | -0.006 | 0 | 0 |
| Interest Expense | -8.98 | -20.18 | 0 |
| Equity & Other Income/(Expense) | 4.55 | 0 | 0 |
| Income Before Tax | 12.65 | 19.4 | -0.085 |
| Income Tax Expense | -8.98 | -20.18 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | 21.63 | 39.58 | -0.085 |
| Depreciation and Amortization | 13.53 | 20.18 | 0.206 |
| EBITDA | 12.65 | 19.4 | 0.121 |
| Earnings Per Share (EPS) | 1.38 | 1.58 | -0.017 |
| Diluted Earnings Per Share | 0.865 | 1.58 | -0.003 |
| Weighted Average Shares Outstanding | 25 | 25 | 5 |
| Diluted Weighted Average Shares Outstanding | 25 | 25 | 25 |
